Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 601–700 of 1,000
Bahl, N., Winarsih, I., Tucker‐Kellogg, L., & Ding, J. L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0220 · Cited by 27
Liu, X., Wang, Z., Zhao, P., Fan, Z., Sun, A., Zhan, F., Fan, Y., & Deng, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112395 · Cited by 28
“which has a rapid reaction rate, accounts for several pathologies such as pulmonary and systemic hypertension, sickle-cell disease [42].”
BackgroundNewaskar, M., Hardy, K. A., & Morris, C. R. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.105 · Cited by 29
“Despite increases in NOS, NO bioavailability is low due to low substrate availability[57], NO scavenging by cell-free hemoglobin released during hemolysis[99] NOS uncoupling[100], and through reactions with free radicals, such as superoxide and other reactive NO species[101].”
BackgroundKato, G. J. (2008) · Hematology · doi:10.1182/asheducation-2008.1.186 · Cited by 30
Group 5 Pulmonary Hypertension
Kalantari, S., & Gomberg‐Maitland, M. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2016.04.004 · Cited by 27
Computed tomography and pulmonary function abnormalities in sickle cell disease
Sylvester, K. P., Desai, S. R., Wells, A. U., Hansell, D. M., Awogbade, M., Thein, S. L., & Greenough, A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00007006 · Cited by 27
“Plasma haemoglobin is a rapid and effective scavenger of nitric oxide (NO), as well as catalysing the formation of reactive oxygen and nitrogen species [ 31 ].”
BackgroundAdenosine deaminase–adenosine pathway in hemolysis-associated pulmonary hypertension
Tofovic, S. P., Jackson, E. K., & Rafikova, O. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.043 · Cited by 27
Stroke in sickle cell disease and the promise of recent disease modifying agents
Runge, A. S., Brazel, D., & Pakbaz, Z. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120412 · Cited by 30
“triphosphate) to cGMP (cyclic guanosine monophosphate), which is required to relax vascular smooth muscle and enable vasodilation [39,43].”
BackgroundOverview of Sickle Cell Anemia Pathophysiology
Steinberg, M. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_3 · Cited by 31
Pizzi, M., Fuligni, F., Santoro, L., Sabattini, E., Ichino, M., Vito, R. D., Zucchetta, P., Colombatti, R., Sainati, L., Gamba, P., et al. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.09.028 · Cited by 27
Louie, J. E., Anderson, C., Fomani, K., Henry, A., Killeen, T. F., Mohandas, N., Yazdanbakhsh, K., Belcher, J. D., Vercellotti, G. M., & Shi, P. A. (2017) · Transfusion · doi:10.1111/trf.14407 · Cited by 28
“The chronic hemolysis of SCD continuously releases Hb into the plasma,(39,40) resulting in steady-state depletion of Hp in 50% to 90% and of Hx in 10% to 30% of patients.(3,41,42) Brazilian children with steady-state SS disease (n 5 173) had mean plasma Hp and Hx levels of 8 and 14% of healthy AA control children, res…”
BackgroundIron Chelation with Transdermal Deferoxamine Accelerates Healing of Murine Sickle Cell Ulcers
Rodrigues, M., Bonham, C. A., Minniti, C. P., Gupta, K., Longaker, M. T., & Gurtner, G. C. (2018) · Advances in Wound Care · doi:10.1089/wound.2018.0789 · Cited by 27
“Increased ROS lead to tissue-free radical defense mechanisms, yielding DNA damage, excessive inflammation, and end-organ damage, among them, chronic ulceration.(9,10) Acute vasoocclusive episodes, typical of SCD, result in severe pain, while ulcers are associated with both acute and chronic pain.”
BackgroundForesti, R., Bains, S. K., Sulc, F., Farmer, P. J., Green, C. J., & Motterlini, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097907 · Cited by 27
“In this respect, it was surprising to observe that coincubation of HbS with NO donors elicited a smaller amplification effect compared with HbA0 because HbS is known to be more susceptible to heme loss (Reiter et al., 2002).”
InfluentialEndothelial dysfunction in Sickle Cell Disease: Strategies for the treatment
Pavan, A. R., Terroni, B., & dos Santos, J. L. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.05.003 · Cited by 27
Rogers, N. M., Yao, M., Sembrat, J., George, M. P., Knupp, H. E., Ross, M., Sharifi‐Sanjani, M., Milošević, J., Croix, C. M. S., Rajkumar, R., et al. (2013) · Pulmonary Circulation · doi:10.1086/674754 · Cited by 26
Self-citationTchernychev, B., Li, H., Lee, S. K., Gao, X., Ramanarasimhaiah, R., Liu, G., Hall, K. C., Bernier, S. G., Jones, J. E., Feil, S. C., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15492 · Cited by 25
“…oxide (NO) in patients with SCD, caused in part by haemolysis, further promotes intravascular inflammation and vaso-occlusion (Kato et al., 2017; Reiter et al., 2002) Lower NO bioavailability results in decreased activation of soluble guanylyl cyclase (sGC), a heterodimeric haem-containing…”
BackgroundCarboxyhemoglobin (COHb): Unavoidable Bystander or Protective Player?
Carrola, A., Romão, C. C., & Vieira, H. L. A. (2023) · Antioxidants · doi:10.3390/antiox12061198 · Cited by 27
“In fact, some hemolytic diseases are associated with hypertension since the lack of NO promotes vasoconstriction [59] (Figure 3).”
BackgroundFerroptosis as an emerging target in sickle cell disease
Fortuna, V., Lima, J. C., Oliveira, G. F., de Oliveira, Y. S. C., Getachew, B., Nekhai, S. A., Aschner, M., & Tizabi, Y. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100181 · Cited by 26
“This release leads to an overload of heme and iron (Reiter et al., 2002).”
BackgroundHanson, M. S., Piknova, B., Keszler, A., Diers, A. R., Wang, X., Gladwin, M. T., Hillery, C. A., & Hogg, N. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08738.x · Cited by 25
“Given that SCD plasma is deficient in haptoglobin (Reiter et al, 2002), we examined whether haptoglobin prevents haem transfer to HSA.”
BackgroundSelf-citationTam, D. H., & Farber, H. W. (2006) · American Journal of Hematology · doi:10.1002/ajh.20603 · Cited by 25
“In addition to its effects on nitric oxide, plasma hemoglobin released during hemolysis leads to the production of reactive oxygen and nitrogen species that could contibute to pulmonary vascular injury and vasoconstriction [39].”
BackgroundPromising Therapies in Sickle Cell Disease
Raghupathy, R., & Billett, H. H. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152909787581354 · Cited by 25
Treating sickle cell anemia: A new era dawns
Steinberg, M. H. (2020) · American Journal of Hematology · doi:10.1002/ajh.25724 · Cited by 28
Sickle red cell adhesion: Many issues and some answers
Kaul, D. K. (2008) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2008.03.012 · Cited by 25
Dahoui, H. A., Hayek, M. N., Nietert, P. J., Arabi, M. T., Muwakkit, S. A., Saab, R. H., Bissar, A. N., Jumaa, N. M., Farhat, F. S., Dabbous, I., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22306 · Cited by 27
“Hemolysis causes release of hemoglobin and arginase from lysed red cells that lead to scavenging of NO and to the catabolism of L-arginine, the obligate substrate for NO synthase [31].”
BackgroundEchocardiographic findings in patients with sickle cell disease
Naoman, S. G., Nouraie, M. S., Castro, O. L., Nwokolo, C., Fadojutimi-Akinsiku, M., Diaz, S. F., Willie-Carnegie, G., Andrews, N., & Gordeuk, V. R. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0764-0 · Cited by 25
“Chronic hemolysis in sickle cell disease patients releases hemoglobin and arginase into the blood plasma, which reduces bioavailability of nitric oxide and increases oxidative stress damage [21].”
BackgroundSomani, A., Steiner, M. E., & Hebbel, R. P. (2010) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2010.05.010 · Cited by 28
“sely with plasma free hemoglobin concentration [60].”
BackgroundZagorski, J., Marchick, M. R., & Kline, J. A. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03704.x · Cited by 26
A role for nitric oxide in hydroxyurea-mediated fetal hemoglobin induction
King, S. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17597 · Cited by 25
The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Moskowitz, D. W., & Johnson, F. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387818 · Cited by 25
“Sickled cells release extracellular hemoglobin, which traps NO [167].”
Sickle Cell Disease and CKD: An Update
Zahr, R. S., & Saraf, S. L. (2023) · American Journal of Nephrology · doi:10.1159/000534865 · Cited by 24
“…Toxicity Haptoglobin and hemopexin, the scavengers of cell-free hemoglobin and heme, respectively, are rapidly consumed, resulting in circulating plasma concentrations of 0 – 20 μ M heme at steady-state increasing to 20 – 40 μ M heme during a vaso-occlusive episode in patients with SCD [71 – 74].”
BackgroundRevisiting the hyperhemolysis paradigm
Gladwin, M. T. (2015) · Blood · doi:10.1182/blood-2015-06-649491 · Cited by 26
Self-citationTissue proteome profiling of preeclamptic placenta using recombinant antibody microarrays
Mellby, L. D., Gerdtsson, A. S., Centlow, M., Nygren, S., Hansson, S. R., Borrebaeck, C. A. K., & Wingren, C. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000001 · Cited by 25
Advances in Sickle Cell Therapies in the Hydroxyurea Era
Field, J. J., & Nathan, D. G. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00187 · Cited by 27
Dzik, S. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03114.x · Cited by 24
“While no conclusive studies have been done yet, there is every reason to believe that scavenging of NO is fundamental to the pathology of disorders characterized by intravascular hemolysis and thrombosis.(20,21) Acute Fig.”
BackgroundArruda, M. A., Barcellos‐de‐Souza, P., Sampaio, A. L. F., Rossi, A. G., Graça-Souza, A. V., & Barja‐Fidalgo, C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.022 · Cited by 24
Sertorio, J. T. C., Neto‐Neves, E. M., Dias-Junior, C. A., Sousa‐Santos, O., Kiss, T., Mühl, D., & Tanus-Santos, J. E. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827c0b43 · Cited by 24
“NO Consumption Assay We used a previously described (14, 24) NO consumption assay to assess NO consumption by plasma samples.”
BackgroundMethodSelf-citationLinking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational–Experimental Approach
Hopp, M.-T., Domingo‐Fernándéz, D., Gadiya, Y., Detzel, M. S., Graf, R., Schmalohr, B. F., Kodamullil, A. T., Imhof, D., & Hofmann‐Apitius, M. (2021) · Biomolecules · doi:10.3390/biom11050644 · Cited by 26
“Moreover, increased heme levels (~20 μM), comparable to hemolytic conditions [100,101], were detected in COVID-19 patients [102], which further supports the importance of the results gained within this study and with respect to the need for developing tailor-made diagnosis and therapeutic strategies for these patients.”
Crane, G. M., & Bennett, N. (2010) · Anemia · doi:10.1155/2011/297364 · Cited by 26
“It is converted to nitrate plus methemoglobin following reaction with oxyhemoglobin and to iron-nitrosylhemoglobin following reaction with deoxyhemoglobin [8].”
Chacko, P., Kraut, E. H., Zweier, J. L., Hitchcock, C. L., & Raman, S. V. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9426-z · Cited by 25
Pulmonary vascular effects of red blood cells containing S-nitrosated hemoglobin
Deem, S. A., Kim, S. S., Min, J.-H., Eveland, R. L., Moulding, J., Martyr, S. E., Wang, X., Swenson, E. R., & Gladwin, M. T. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00310.2004 · Cited by 25
“This is consistent with the function of the RBC membrane as a diffusion barrier that limits NO inactivation (10, 13, 20, 24).”
BackgroundSelf-citationClinical trials in sickle cell disease: Adopting the combination chemotherapy paradigm
Steinberg, M. H. (2007) · American Journal of Hematology · doi:10.1002/ajh.21033 · Cited by 26
“Erythrocytes also release arginase, which destroys L-arginine, the substrate for NO synthases [6].”
BackgroundBobade, D., Khandare, A. V., Deval, M., Shastry, P., & Deshpande, P. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.651 · Cited by 24
Tantawy, A. A. G., Adly, A. A. M., Ismail, E. A. R., & Aly, S. H. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25234 · Cited by 27
“These data suggests that adequate arginine bioavailability is critical for survival and provide clinicians with an objective index of disease severity [34].”
BackgroundGrau, M., Jerke, M., Nader, É., Schenk, A., Renoux, C., Collins, B., Dietz, T., Bizjak, D. A., Joly, P., Bloch, W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48364-1 · Cited by 24
Priapism and Sickle Cell Disease: Special Considerations in Etiology, Management, and Prevention
Ahuja, G., Ibecheozor, C., Okorie, N., Jain, A. J., Coleman, P. W., Metwalli, A. R., & Tonkin, J. B. (2021) · Urology · doi:10.1016/j.urology.2021.06.010 · Cited by 23
Nader, É., Garnier, Y., Connes, P., & Romana, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.728693 · Cited by 25
Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias
Ricci, A., Pierro, E. D., Marcacci, M., & Ventura, P. (2021) · Diagnostics · doi:10.3390/diagnostics11122205 · Cited by 23
“NOS is also found throughout the neuronal populations of the myenteric plexus [122], where its dysfunction causes a number of dysautonomic gastrointestinal symptoms, as has been described for patients with nocturnal paroxysmal hemoglobinuria and sickle cell anemia [123,124].”
BackgroundWatts, J. A., Gellar, M. A., Fulkerson, M.-B. K., Das, S. K., & Kline, J. A. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.10.005 · Cited by 23
Methemoglobin-induced signaling and chemokine responses in human alveolar epithelial cells
Mumby, S. E., Ramakrishnan, L., Evans, T. W., Griffiths, M., & Quinlan, G. J. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00066.2013 · Cited by 23
“During hemolytic events the release of tetrameric oxyhemoglobin is followed by dissociation of the parent tetramer into dimers, the majority of which are comprised of oxyhemoglobin with some ( 10%) present in the methemoglobin form (4, 42, 49).”
BackgroundKnight‐Perry, J. E., Fuentes, L. D. L., Waggoner, A. D., Hoffmann, R. G., Blinder, M. A., Dávila‐Román, V. G., & Field, J. J. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.07.009 · Cited by 24
dos Santos, T. E. D. J., Gonçalves, R. P., Barbosa, M. C., da Silva, G. B., & Daher, E. D. F. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.11.019 · Cited by 23
Automated red cell exchange procedures in patients with sickle cell disease
Kozanoğlu, İ., Boğa, C., Özdoğu, H., Sezgin, N., Kızılkılıç, E., & Kural, M. (2007) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2007.03.012 · Cited by 23
Hydroxyurea with AKT2 inhibition decreases vaso-occlusive events in sickle cell disease mice
Barazia, A., Li, J., Kim, K., Shabrani, N. C., & Cho, J. (2015) · Blood · doi:10.1182/blood-2015-02-626234 · Cited by 23
cGMP modulation therapeutics for sickle cell disease
Conran, N., & Torres, L. S. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219827276 · Cited by 24
Chalacheva, P., Kato, R. M., Shah, P., Veluswamy, S., Denton, C. C., Sunwoo, J., Thuptimdang, W., Wood, J. C., Detterich, J. A., Coates, T. D., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00381 · Cited by 25
Sickle Cell Disease: Metabolomic Profiles of Vaso-Occlusive Crisis in Plasma and Erythrocytes
Dembélé, K. C., Veyrat‐Durebex, C., Guindo, A., Chupin, S., Tessier, L., Goïta, Y., Baraïka, M. A., Diallo, M., Touré, B. A., Homedan, C., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041092 · Cited by 26
“More than 100 biomarkers have been reported in sickle cell disease, such as the disruption of the arginine and nitric oxide (NO) metabolism at the origin of sickle cell vasculopathy [2,3].”
BackgroundGonzales, J., Holbert, K., Czysz, K., George, J. T., Fernandes, C., & Fraidenburg, D. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094763 · Cited by 24
“In SCD cohorts, prior studies have identified increased concentrations of free hemoglobin and hemin, the oxidized moiety of heme, in the steady state plasma of individuals with SCD when compared to individuals without [11,12].”
BackgroundMittal, H., Roberts, L. N., Fuller, G. W., O’Driscoll, S., Dick, M. C., Height, S. E., Thein, S. L., & Rees, D. C. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0598-1 · Cited by 25
Pancreatic ascites hemoglobin contributes to the systemic response in acute pancreatitis
Pérez, S., Pereda, J., Sabater-Orti, L., & Sastre, J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.008 · Cited by 25
Sopko, N. A., Matsui, H., Hannan, J. L., Berkowitz, D. E., Champion, H. C., Hsu, L. L.-Y., Musicki, B., Burnett, A. L. “., & Bivalacqua, T. J. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12976 · Cited by 23
Ikuta, T., Sellak, H., Odo, N., Adekile, A. D., & Gaensler, K. M. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144561 · Cited by 23
HbS Binding to GP1bα Activates Platelets in Sickle Cell Disease
Annarapu, G. K., Singhal, R., Gupta, A., Chawla, S., Batra, H., Seth, T., & Guchhait, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167899 · Cited by 25
Urease enhances the formation of iron nitrosyl hemoglobin in the presence of hydroxyurea
Lockamy, V. L., Huang, J., Shields, H. W., Ballas, S. K., King, S. B., & Kim‐Shapiro, D. B. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00132-6 · Cited by 23
Giustarini, D., Dalle‐Donne, I., Colombo, R., Milzani, A., & Rossi, R. (2004) · Free Radical Research · doi:10.1080/10715760400008854 · Cited by 26
“Na-salicylate, naproxen and ketorolac) at therapeutic concentrations([31,32]) can also hemolyze RBCs causing an increase in the plasma GSH pool.”
BackgroundTherapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction
Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32
Self-citationImmune regulation of sickle cell alloimmunization
Yazdanbakhsh, K., Shaz, B. H., & Hillyer, C. D. (2016) · ISBT Science Series · doi:10.1111/voxs.12296 · Cited by 24
Pethő, D., Hendrik, Z., Nagy, A., Beke, L., Patsalos, A., Nagy, L., Póliska, S., Méhes, G., Tóth, C., Potor, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89713-3 · Cited by 24
Harp, K. O., Bashi, A., Botchway, F. A., Dei‐Adomakoh, Y., Iqbal, S. A., Wilson, M. D., Adjei, A. A., Stiles, J. K., & Driss, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030500 · Cited by 23
“In SCA, the HbS genotype causes hemolytic anemia, leading to the accumulation of high levels of cell-free Hb and free heme in plasma [71,72].”
BackgroundNeutrophils as drivers of vascular injury in sickle cell disease
Torres, L. S., & Hidalgo, A. (2022) · Immunological Reviews · doi:10.1111/imr.13146 · Cited by 27
Kehinde, M., Ogungbemi, S. I., Anigbogu, C. N., & Jaja, S. I. (2015) · Pathophysiology · doi:10.1016/j.pathophys.2015.05.001 · Cited by 22
Benza, R. L. (2008) · Lung · doi:10.1007/s00408-008-9092-8 · Cited by 23
“Reproduced with permission from [56]”
Biologic Complexity in Sickle Cell Disease: Implications for Developing Targeted Therapeutics
Gee, B. E. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/694146 · Cited by 25
“Cell-free hemoglobin has been found to reduce NO concentrations [25].”
BackgroundArkuszewski, M., Krejza, J., Chen, R., Kwiatkowski, J. L., Ichord, R., Zimmerman, R. A., Ohene‐Frempong, K., Desiderio, L. M., & Melhem, E. R. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2529 · Cited by 22
Kaul, D. K., Fabry, M. E., Suzuka, S. M., & Zhang, X. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00296.2012 · Cited by 25
Rusak, T., Misztal, T., Piszcz, J. A., & Tomasiak, M. (2013) · Free Radical Research · doi:10.3109/10715762.2013.860225 · Cited by 25
Dynamic interactions ofPlasmodiumspp. with vascular endothelium
Gillrie, M. R., & Ho, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1268667 · Cited by 22
“derangements are compounded by the increased cell-free hemoglobin circulating in malaria patients secondary to hemolysis, leading to increased NO scavenging and plasma L-arginine catabolism, and an overall reduction in NO bioavailability as seen in sickle cell disease.(89) Increased arginase activity has also been dem…”
BackgroundDecreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients
Aslan, M., Kıraç, E., Kaya, S., Özcan, F., Salim, O., & Küpesiz, O. A. (2018) · Lipids · doi:10.1002/lipd.12027 · Cited by 22
Kozlova, E. K., Sherstyukova, E. A., Sergunova, V. A., Козлов, А. П., Гудкова, О. Е., Inozemtsev, V. A., & Черныш, А. М. (2022) · Journal of Toxicology · doi:10.1155/2022/7113958 · Cited by 23
“Overload of free iron in the blood has different origins: chronic iron overload is a common complication of repeated packed red blood cell (pRBC) transfusions [1, 4–6]; disorders of iron metabolism and chronic iron overload are observed in a number of acute and chronic inflammatory diseases and in acute respiratory di…”
BackgroundMechanisms and Clinical Complications of Hemolysis in Sickle Cell Disease and Thalassemia
Kato, G. J., & Gladwin, M. T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.016 · Cited by 27
Self-citationEfficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers
Lionnet, F., Bachmeyer, C., Stankovic, K., Tharaux, P., Girot, R., & Aractingi, S. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07206.x · Cited by 22
“Indeed, in SCA, high levels of endothelin-1 (Hebbel & Vercelloti, 1997; Tharaux et al, 2005) and impaired bioavailability of nitric oxide (Reiter et al, 2002) exist, and lead to vasoconstriction and vasculopathy.”
BackgroundToh, R. J., Peng, W. K., Han, J., & Pumera, M. (2014) · RSC Advances · doi:10.1039/c3ra45417g · Cited by 23
Effects of a Single Sickling Event on the Mechanical Fragility of Sickle Cell Trait Erythrocytes
Presley, T. D., Perlegas, A. S., Bain, L. E., Ballas, S. K., Nichols, J. S., Sabio, H., Gladwin, M. T., Kato, G. J., & Kim‐Shapiro, D. B. (2010) · Hemoglobin · doi:10.3109/03630260903546999 · Cited by 22
“Hemolysis in sickle cell anemia and other hemolytic anemias contribute to pathology via reduced nitric oxide (NO) bioavailability (12-21) and oxidative damage (22-28).”
BackgroundSelf-citationAN OVERVIEW ON SICKLE CELL DISEASE PROFILE
Kaur, M., Dangi, C. B. S., & Singh, M. (2013) · Cited by 22
Hipertensão arterial pulmonar associada à anemia falciforme
Machado, R. F. (2007) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132007000500015 · Cited by 30
Antwi‐Boasiako, C., Donkor, E. S., Sey, F., Dzudzor, B., Dankwah, G. B., Otu, K. H., Doku, A., Dale, C. A., & Ekem, I. A. E. (2018) · Diseases · doi:10.3390/diseases6020029 · Cited by 22
“Sub-phenotypes of SCD including priapism and leg ulcers are associated with increased hemolysis [30,31], a decrease in the NO precursor, L-arginine [32,33], reduced NO bioavailability [34], and a disruption of the coagulation cascade [35].”
BackgroundNitric oxide and sickle cell disease—Is there a painful connection?
Hallmark, L., Almeida, L. E. F., Kamimura, S., Smith, M. L., & Quezado, Z. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220976397 · Cited by 22
“For example, despite methodological limitations mentioned previously, researchers measuring plasma NOx (nitrite and nitrate combined) concentrations in SCD patients and controls showed that these NO metabolites were elevated in SCD patients at steady state.79 This was corroborated by a later study showing an eight-fol…”
BackgroundInfluentialEpidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension
Al‐Qadi, M. O., LeVarge, B. L., & Ford, H. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.616720 · Cited by 25
“(107) Prospective open label 16 weeks (15) Inh iloprost (15) Decreased mPAP and PVR in 6 of 15 and”
BackgroundPereira, P. D. S., Pereira, D. A., Calmasini, F. B., Reis, L. O., Brinkman, N. J., Burnett, A. L. “., Costa, F. F., & Silva, F. H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.961534 · Cited by 23
“The process of intravascular hemolysis leads to the release of hemoglobin into the plasma (Reiter et al., 2002).”
BackgroundInfluentialQuast, C., Bönner, F., Polzin, A., Veulemans, V., Chennupati, R., Gyamfi-Poku, I., Pfeiler, S., Kramser, N., Nankinova, M., Staub, N., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.064747 · Cited by 21
Navigating Hemolysis and the Renal Implications of Hemoglobin Toxicity in Cardiac Surgery
Schaer, D. J., Schaer, C. A., Humar, R., Vallelian, F., Henderson, R. A., Tanaka, K. A., Levy, J. H., & Buehler, P. W. (2024) · Anesthesiology · doi:10.1097/aln.0000000000005109 · Cited by 25
“46,48,49 NO can react with CFHb near the vascular wall or after CFHb extravasation.”
The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease
Küpesiz, A., Çelmeli, G., Doğan, S., Antmen, B., & Aslan, M. (2012) · Free Radical Research · doi:10.3109/10715762.2012.686037 · Cited by 24
“033 g/dl cell-free ferrous haemoglobin, which stoichiometrically can consume micromolar quantities of nitric oxide and abrogate forearm blood fl ow responses to infusion of NO donors [5].”
BackgroundInfluentialPawlak, M. A., Krejza, J., Rudziński, W., Kwiatkowski, J. L., Ichord, R., Jawad, A. F., Tomaszewski, M., & Melhem, E. R. (2009) · Radiology · doi:10.1148/radiol.2512071180 · Cited by 21
“In children with SCD, altered resistance and reactivity may counterbalance sex differences in Doppler parameters (13,38,39).”
Backgroundfor the PRONOBURN group, Dépret, F., Dunyach, C., de Tymowski, C., Chaussard, M., Bataille, A., Ferry, A., Moreno, N., Cupaciu, A., Soussi, S., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1837-4 · Cited by 21
“Haemolysis has also been described as a strong causal factor for AKI in other situations such as sickle cell disease [10, 11] or after cardiopulmonary bypass for cardiovascular surgery [12, 13].”
BackgroundCell free hemoglobin in the fetoplacental circulation: a novel cause of fetal growth restriction?
Brook, A., Hoaksey, A., Gurung, R., Yoong, E. E. C., Sneyd, R., Baynes, G. C., Bischof, H., Jones, S., Higgins, L. E., Jones, C. J. P., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800264r · Cited by 21
“(20, 21) However, in its extracellular (free) form, sequestration of NO by oxyhemoglobin occurs instantaneously.”
Nitric Oxide in Post-cardiac Arrest Syndrome
Miyazaki, Y., & Ichinose, F. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000765 · Cited by 22
Red blood cells from patients with pre-eclampsia induce endothelial dysfunction
Haworth, S. M., Zhuge, Z., Nihlén, C., Rosen, M. F. V., Weitzberg, E., Lundberg, J. O., Krmar, R. T., Nasiell, J., & Carlström, M. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002834 · Cited by 21
“Long-term exposure to cell-free haemoglobin has been associated with inflammation, decreased NO bioavailability and oxidative stress [67,68].”
BackgroundNitric oxide scavenging by hemoglobin regulates hypoxic pulmonary vasoconstriction
Deem, S. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.025 · Cited by 21
Rassaf, T., Kleinbongard, P., & Kelm, M. (2005) · Kidney & Blood Pressure Research · doi:10.1159/000090188 · Cited by 23
“and supports the idea of a novel function for nitrite in the regulation of hypoxic vasodilation. This raises the question whether the application of nitrite may open new avenues for therapeutical approaches. Nitrite infusions may be used for selective NO delivery to ischemic sites at high risk for ischemia-reperfusion…”
BackgroundHydroxyurea and Sickle Cell Disease
Weiner, D. L., & Brugnara, C. (2003) · JAMA · doi:10.1001/jama.289.13.1692 · Cited by 21
Alagbe, A. E., Justo Junior, A. S., Ruas, L. P., Tonassé, W. V., Santana, R. M., Batista, T. H. C., Domingos, I. F., Araujo, A. S., Bezerra, M. A. C., Santos, M. N. N., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2017.12.001 · Cited by 20
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.